Structured Treatment and Long-Term Recovery: What the Evidence Says About Men's Addiction Outcomes in Canada
Published April 12th 2026
Canada is in the middle of an addiction crisis that shows no signs of resolution. More than 49,000 Canadians have died from opioid toxicity since 2016. Accidental poisonings remain the leading cause of death for Canadian males aged 20 to 49. British Columbia, home to some of the country's most advanced harm reduction and treatment infrastructure, continues to report the highest concentration of opioid-related fatalities in the nation.
Yet for all the attention directed toward the crisis, a fundamental question remains underexplored in public discourse: why do some treatment approaches produce lasting recovery while others do not? Research from the University of British Columbia and Harvard Medical School, published in JAMA Psychiatry, found that globally only 6.9 per cent of people who meet the criteria for a mental health or substance use disorder receive effective treatment. The treatment gap is not just about access. It is about what happens once someone enters care.
For men in particular, who represent 74 per cent of opioid toxicity deaths in Canada and who are statistically less likely to seek treatment voluntarily, the structure, design, and gender-responsiveness of a treatment program may determine whether recovery lasts months or a lifetime.
The Case for Structured Treatment Models
Not all addiction treatment is created equal. A growing body of clinical research distinguishes between treatment programs based on their structural characteristics, including daily routine, accountability mechanisms, peer interaction models, and the sequencing of therapeutic interventions over time.
Research published in the Journal of Substance Abuse Treatment has examined the relationship between program structure and treatment retention. The findings consistently point in the same direction: programs that impose clear expectations, defined daily schedules, and progressive milestone-based advancement produce higher retention rates and better long-term sobriety outcomes than programs with less defined frameworks.
This finding has particular relevance for men. Behavioral research on male populations in treatment settings indicates that men respond more effectively to environments where expectations are explicit, where progress is measurable, and where peer accountability is built into the program model rather than left to individual initiative. In practical terms, this means a program where every man follows the same structured daily routine, where group accountability is enforced, and where each phase of recovery has defined criteria for advancement.
The clinical rationale is straightforward. Addiction disrupts the executive functioning systems of the brain, the systems responsible for planning, impulse control, and goal-directed behaviour. A structured treatment environment externally imposes the discipline and routine that the brain is temporarily unable to generate on its own. Over time, as neurological function recovers, the individual internalizes these patterns and becomes capable of sustaining them independently.
Why Gender Matters in Treatment Design
The Mental Health Commission of Canada has documented the role of stigma in preventing men from seeking treatment for substance use disorders. Men are more likely to frame addiction as a personal failure, and cultural expectations around masculinity create barriers to emotional disclosure and help-seeking behaviour that do not affect women to the same degree.
These barriers do not disappear at the door of a treatment facility. In mixed-gender treatment settings, research on group therapy dynamics has found that men are less likely to participate openly, less likely to disclose relapse triggers, and more likely to adopt performative behaviours that interfere with therapeutic progress. The presence of women in the group changes what men are willing to say and how they say it.
Gender-specific treatment addresses this problem directly. Rehab programs for men that operate in single-gender environments report higher rates of honest disclosure, stronger peer accountability, and improved program completion rates. The mechanism is not ideological. It is practical: men are more candid when surrounded by other men facing the same challenges, and candour is a prerequisite for effective therapeutic work.
This aligns with research from UBC's own Addictions and Concurrent Disorders Research Group, which has emphasized the importance of person-centred approaches that address the unique circumstances of each population. Dr. Eugenia Oviedo-Joekes, Canada's first Tier 1 Research Chair in person-centred care in addictions, has argued that effective treatment must be tailored to the individual and systemic factors that shape a person's relationship with substances. Gender is one of the most significant of those factors.
The Continuum Problem
One of the most persistent failures in addiction treatment is the gap between residential care and independent living. A man who completes 30 or 60 days of inpatient treatment and is then discharged back into the same environment that fuelled his addiction faces a predictable set of risks: exposure to the same social triggers, the same access to substances, and the same absence of structured support.
Research on relapse patterns has found that the period immediately following discharge from residential treatment is the highest-risk window for return to use. The transition from a controlled environment to independent living is where many recovery journeys end.
Multi-stage treatment models attempt to address this vulnerability by extending the continuum of care beyond the initial residential phase. These models typically include a transitional stage, where the individual begins to reintroduce elements of independent living while still maintaining structured support, followed by a long-term sober living phase that provides community-based accountability over a period of months.
The evidence supporting this approach is strong. Studies comparing single-stage programs to multi-stage continuum models have found that individuals who progress through phased recovery are significantly more likely to maintain sobriety at one-year and three-year follow-up points. The explanation is straightforward: recovery is a process that requires more time and more scaffolding than a single residential stay can provide.
British Columbia as a Case Study
BC provides a useful case study in the gap between treatment availability and treatment effectiveness. The province declared a public health emergency over toxic drugs in 2016, and since then more than 15,000 lives have been lost. BC has invested heavily in harm reduction, supervised consumption, and naloxone distribution. These interventions save lives in the immediate term, and their importance should not be minimized.
However, harm reduction and treatment are not substitutes for each other. They address different stages of the same problem. A naloxone kit can reverse an overdose. A supervised consumption site can prevent a solitary death from becoming an unwitnessed one. But neither intervention addresses the underlying substance use disorder that places an individual at risk in the first place.
The treatment infrastructure in BC reflects the broader Canadian challenge. Publicly funded programs face long wait times and limited capacity. The Canadian Institute for Health Information has reported that wait times for publicly funded addiction treatment can extend from weeks to months. Private programs offer faster admission but carry costs that range from $10,000 to $30,000 per month.
For men in BC, who represent the majority of opioid-related deaths in the province, the combination of delayed access, mixed-gender default programming, and single-stage treatment models creates a system that is misaligned with what the evidence says works best.
Policy Implications
The research points toward several evidence-based policy directions that could meaningfully improve addiction treatment outcomes for men in Canada.
Expanding access to gender-specific treatment should be a priority. The evidence supports the effectiveness of single-gender environments for men, and the current treatment infrastructure does not offer sufficient capacity in this area. Publicly funded programs should be encouraged to develop gender-specific tracks, and private programs operating gender-specific models should be considered for provincial partnership arrangements.
Multi-stage treatment continuum models should be incentivized. Single-stage residential programs remain the default in much of the Canadian treatment landscape, despite evidence that phased models produce superior long-term outcomes. Policy frameworks that fund or subsidize multi-stage care, including transitional and sober living phases, would align the treatment system with the evidence base.
Early intervention pathways for men need expansion. The current system relies heavily on crisis-driven entry points such as emergency departments and the criminal justice system. Men who are not yet in crisis but who are at risk represent a population that the system is poorly equipped to reach. Workplace-based screening, primary care integration, and community-level awareness campaigns designed specifically for men could reduce the proportion of men who enter treatment only after catastrophic consequences.
The UBC research community has laid significant groundwork in understanding both the barriers to effective treatment and the characteristics of programs that produce lasting outcomes. The next step is translating that evidence into a treatment infrastructure that applies what the data has been showing for years: that treatment structure matters, that gender matters, and that the continuity of care after residential treatment may matter most of all.